diphenylamine has been researched along with Disease Exacerbation in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, MS; Fenster, T; Ilkhanizadeh, S; Jakobsson, J; Jandial, R; Martinez, M; Masic, S; Nicolaides, TP; Persson, AI; Petri, R; Sabelström, H; Sacheva, R; Saxena, S; Schmidt, C; Shchors, K; Snyder, EY; Weiss, WA; Yuan, E | 1 |
Domany, E; Eichhorn, PJA; Ha, HK; Haviv-Shapira, L; Iyengar, PV; Jaynes, PW; Kappei, D; Kumar, AP; Lama, D; Lui, SKL; Ng, HC; Radulescu, C; Rouanne, M; Saei, A; Sim, WJ; Tan, TZ; Ten Dijke, P; Thiery, JP; Verma, CS | 1 |
De Vos, J; Klein, B; Moreaux, J; Veyrune, JL | 1 |
Bedja, D; Chen, Y; Cohn, RD; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Kim, D; Lindsay, ME; Loeys, BL; Marugan, JJ; Patnaik, S; Schoenhoff, F; Thomas, CJ; van Erp, C | 1 |
4 other study(ies) available for diphenylamine and Disease Exacerbation
Article | Year |
---|---|
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness.
Topics: Animals; Astrocytoma; Benzamides; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Survival; Diphenylamine; Disease Progression; Female; Glioblastoma; Humans; Male; MAP Kinase Signaling System; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplastic Stem Cells; Neurogenesis; Neurons; Phenotype; Protein Kinase Inhibitors; Radiation Tolerance; SOX9 Transcription Factor | 2019 |
c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression.
Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Disease Progression; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Kaplan-Meier Estimate; Mice, Inbred BALB C; Mice, Nude; Proto-Oncogene Proteins c-met; Pyrazoles; Quinolines; Receptors, Transforming Growth Factor beta; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2019 |
APRIL is overexpressed in cancer: link with tumor progression.
Topics: B-Cell Activating Factor; B-Cell Activation Factor Receptor; B-Lymphocytes; Biomarkers, Tumor; Carcinoma; Cell Proliferation; Cell Survival; Diphenylamine; Disease Progression; Heparin; Humans; Lymphoma; Multiple Myeloma; Neoplasm Staging; Oligonucleotide Array Sequence Analysis; Prognosis; Protein Binding; Proteoglycans; Thyroid Neoplasms; Transmembrane Activator and CAML Interactor Protein; Tumor Necrosis Factor Ligand Superfamily Member 13 | 2009 |
Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice.
Topics: Animals; Anthracenes; Aorta; Aortic Aneurysm; Diphenylamine; Disease Models, Animal; Disease Progression; Enzyme Activation; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Protein Kinase Inhibitors; Smad2 Protein; Smad4 Protein; Sulfonamides; Transforming Growth Factor beta | 2011 |